The demand for weight-loss medications like Ozempic, Wegovy, and Mounjaro has surged, with a recent study estimating that one in eight Americans has used these drugs to manage diabetes, heart disease, or obesity.
While often referred to as “miracle drugs” for their effectiveness in promoting weight loss, scientists are still uncovering their broader effects on the body.
A new study led by Washington University School of Medicine in St. Louis and the Veterans Affairs (VA) St. Louis Health Care System sheds light on both the benefits and risks of these medications, offering critical insights for their safe use.
Study Overview
The drugs, formally known as glucagon-like peptide-1 receptor agonists (GLP-1RAs), mimic natural hormones that reduce appetite and slow digestion, helping users feel fuller for longer.
In addition to weight loss, these medications have been shown to reduce the risk of heart attack and stroke. However, less is known about their effects on other organ systems.
To address this, researchers analyzed de-identified medical records from over 2 million veterans with diabetes treated between 2017 and 2023.
They compared outcomes among those using GLP-1RAs and those on traditional diabetes medications like Jardiance, Glipizide, and Januvia. The study evaluated 175 health outcomes, creating a comprehensive map of the drugs’ effects across the body.
Key Findings: Benefits of GLP-1RAs
Neurological and Behavioral Health:
GLP-1RAs were associated with reduced risks of neurological and psychiatric disorders, including:
-
- Seizures
- Addiction to substances such as alcohol, cannabis, and opioids
- Suicidal ideation and self-harm
- Eating disorders like bulimia
- Psychotic disorders, including schizophrenia
The drugs also showed potential in reducing neurocognitive disorders, such as Alzheimer’s disease and dementia. Researchers believe these benefits stem from the drugs’ effects on brain receptors involved in impulse control and reward, as well as their ability to reduce brain inflammation.
Cardiovascular Health:
Consistent with previous studies, GLP-1RAs were linked to lower risks of heart attack, stroke, and other cardiovascular conditions. These benefits are significant for managing diabetes, which often increases the risk of heart disease.
Behavioral and Cognitive Improvement:
By acting on brain regions related to appetite and addiction, these drugs not only promote weight loss but may also improve overall brain health. This dual action could explain their potential effectiveness in treating conditions like addiction and dementia.
Modest Benefits Across Outcomes:
While the reductions in risk for most conditions were modest (10–20%), the potential to improve conditions with limited treatment options, such as Alzheimer’s, highlights the broader value of these medications.
Risks and Side Effects
The study also highlighted important risks associated with GLP-1RAs:
Gastrointestinal Issues:
Common side effects include nausea, vomiting, diarrhea, and, in rare cases, paralysis of the stomach. These are well-documented and should be monitored closely.
Pancreas and Kidney Risks:
The study revealed a small but serious risk of pancreatitis (inflammation of the pancreas) and kidney problems. These adverse effects are rare but can be severe, with kidney issues often progressing silently until advanced stages. Physicians are advised to monitor kidney function and watch for signs of pancreatitis in patients using these medications.
Implications for Clinical Use
Dr. Ziyad Al-Aly, the study’s senior author, emphasized the importance of balancing the benefits and risks of GLP-1RAs. While the drugs show promise for treating a range of conditions, their effectiveness is often modest, and they should ideally be used alongside lifestyle changes or other treatments.
The findings also suggest potential new applications for GLP-1RAs beyond diabetes and weight loss, particularly in neurological and psychiatric care. However, close monitoring of side effects, especially in the pancreas and kidneys, is critical to ensure patient safety.
Conclusion
This comprehensive study provides valuable insights into the widespread effects of GLP-1RAs, demonstrating their potential to improve not only weight management but also neurological, behavioral, and cardiovascular health.
At the same time, it underscores the importance of vigilance for rare but serious side effects. As these medications become increasingly popular, ongoing research and careful monitoring will be essential to maximize their benefits while minimizing risks.
If you care about diabetes, please read studies about Vitamin D and type 2 diabetes, and to people with diabetes, some fruits are better than others.
For more health information, please see recent studies that low calorie diets may help reverse diabetes, and 5 vitamins that may prevent complication in diabetes.
The research findings can be found in Nature Medicine.
Copyright © 2025 Knowridge Science Report. All rights reserved.
